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Signal transduction pathways involving calcineurin and its downstream effector NFAT have been implicated in regulating
myogenesis. Several isoforms of NFAT exist that may differentially contribute to regulating skeletal muscle physiology. The
purpose of this study was to determine the role of the NFATC3 isoform in skeletal muscle development. Adult mice lacking
NFATC3 have reduced muscle mass compared to control mice. The smaller size of the muscles is not due to atrophy or blunted
myofiber growth, but rather to a reduced number of myofibers. This reduction in myofiber number is not limited to a specific fiber
type nor are the proportions of fiber types altered. The lower fiber number found in the adult NFATC32/2 mice is a consequence
f impaired muscle development during embryogenesis. Immunohistochemical studies of E15 EDL muscles indicate that the
otal number of primary myofibers is decreased in NFATC32/2 embryos. At E17.5 no further decrease in primary myofiber
number occurs; the size and organization of the myofibers are unaltered, and secondary myogenesis proceeds normally,
suggesting a role for NFATC3 during early events in primary myogenesis. These results suggest a heretofore unknown role for
the transcription factor NFAT in early skeletal muscle development. © 2001 Academic Press
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A large body of work has demonstrated that calcium and
calcium-dependent pathways are required for myogenesis.
Calcineurin, a calcium-calmodulin regulated serine/
threonine protein phosphatase, is one molecular target of
calcium. Recently, calcineurin has been implicated in regu-
lating several aspects of skeletal muscle physiology: expres-
sion of myogenic regulatory factor (MRF) genes (Friday and
Pavlath, 2001), myoblast differentiation (Delling et al.,
2000; Friday et al., 2000), hypertrophy (Dunn et al., 1999;
Musaro et al., 1999; Semsarian et al., 1999), and regulation
of slow fiber-specific gene expression (Chin et al., 1998;
igard et al., 2000; Delling et al., 2000; Naya et al., 2000).
These pathways have been variously ascribed to different
downstream mediators of calcineurin signaling. One down-
stream target of calcineurin is the transcription factor
nuclear factor of activated T cells (NFAT; for review see
1 To whom correspondence should be addressed at Emory Uni-
versity School of Medicine, Department of Pharmacology, Room
5027, O. W. Rollins Research Building, Atlanta, GA 30322. E-mail:
gpavlat@emory.edu.
0012-1606/01 $35.00
Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.Rao et al., 1997). Four calcium responsive isoforms of
NFAT with a high degree of homology to each other are
known: NFATC1, NFATC2, NFATC3, and NFATC4.
Originally NFAT expression was thought to be restricted to
the T-cell lineage, but subsequently NFAT proteins have
been found in numerous cell types, including skeletal
muscle (Abbott et al., 1998). Our previous immunohisto-
chemical studies demonstrated that skeletal muscle cells
express NFATC1, NFATC2, and NFATC3 and suggested
that these specific NFAT isoforms expressed in muscle may
regulate distinct physiological pathways during myogenesis
(Abbott et al., 1998). Here, using knockout mice (Oukka et
al., 1998), we directly test the role of the NFATC3 isoform
in muscle development during embryogenesis and in
muscle function and composition postnatally.
All NFAT proteins undergo rapid calcium-dependent
shuttling between the cytoplasm and the nucleus. Under
basal conditions, NFAT exists as a phosphorylated species
in the cytoplasm. Substained increases in intracellular
calcium lead to activation of calcineurin and the subse-
quent dephosphorylation of NFAT (Dolmetsch et al., 1997).
The dephosphorylated NFAT translocates to the nucleus
and binds to its consensus DNA binding site in combina-
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116 Kegley et al.tion with other transcription factors to regulate gene ex-
pression. This binding partner of NFAT differs depending
on the cell type: AP-1 (Northrop et al., 1993) and ATF-2/Jun
(Tsai et al., 1996) in lymphocytes, MEF2 (Chin et al., 1998)
or GATA2 (Musaro et al., 1999) in skeletal muscle, GATA4
in cardiac muscle (Molkentin et al., 1998; Xia et al., 2000),
and HNF-3b in liver (Furstenau et al., 1999). The nuclear
ocalization of NFAT is dependent on continued calcium
ignaling. Rapid rephosphorylation and nuclear export of
FAT occurs in minutes with the cessation of a calcium
ignal (Shibasaki et al., 1996). The nuclear export of NFAT
s regulated by several protein kinases; these include casein
inase 1a (Zhu et al., 1998), glycogen synthase kinase 3
Beals et al., 1997), and c-Jun-N-terminal kinase (Chow et
l., 1997). Thus, the nuclear localization of NFAT proteins
s regulated by the opposing actions of protein kinases and
he phosphatase calcineurin.
Although the NFAT isoforms all bind to the same DNA
onsensus sequence, numerous lines of evidence suggest,
ut do not prove, a lack of functional redundancy among
he isoforms, as follows:
(1) NFAT isoforms differ in their tissue distribution
Hoey et al., 1995).
(2) NFAT isoforms differ in their binding affinity for the
onsensus NFAT DNA sequence (Ho et al., 1995) and in
heir transactivation domains (Imamura et al., 1998; Luo et
l., 1996).
(3) The target genes regulated by specific NFAT isoforms
iffer. For example, NFATC4 plays a role in expression of
asoactive intestinal peptide in neural cells (Symes et al.,
998), whereas NFATC2 has been implicated in expression
f glucagon in islet cells (Furstenau et al., 1999). Even in T
ells, specific NFAT isoforms differ in their binding to the
ell-characterized NFAT enhancer sites in the IL-2 and II-4
enes (Timmerman et al., 1997).
(4) Some NFAT isoforms and not others can be targeted
or nuclear export by a specific kinase. Thus, c-Jun-N-
erminal kinase regulates nuclear export of NFATC3 but
ot of NFATC4 (Chow et al., 1997).
The use of mice with targeted mutations in specific
soforms of NFAT directly demonstrates functional differ-
nces among individual NFAT isoforms in specific tissue
ypes. Alterations in immune cell function occur when the
FATC2 (Hodge et al., 1996; Xanthoudakis et al., 1996) or
FATC3 (Oukka et al., 1998) isoforms are eliminated.
FATC22/2 immune cells display a hyperproliferative re-
ponse, whereas an increase in specific T-cell subsets oc-
urs in NFATC32/2 mice secondary to decreases in the
ntiapoptotic protein bcl-2. Chondrogenesis is induced in
oft tissues with advanced age in NFATC22/2 mice (Ranger
et al., 2000), implicating NFATC2 as a repressor of cartilage
cell growth and differentiation. Defects in muscle tissue are
also observed in the absence of specific NFAT isoforms.
Cardiac development is abnormal in NFATC12/2 mice
leading to embryonic lethality at day 12 of embryogenesis
(Ranger et al., 1998). Thus, individual NFAT isoforms
Copyright © 2001 by Academic Press. All rightappear to play important roles in several tissue types at
various stages of development from the embryo through
postnatal development.
In this study, we show that slow and fast skeletal muscles
of adult NFATC32/2 mice exhibit significant decreases in
uscle mass due to reduced myofiber number. The de-
reased myofiber number in the mutant muscles occurs
ithout any detectable change in fiber type proportions,
uggesting that neural input to the muscles is not altered.
he reduced myofiber number present in adult NFATC32/2
mice is due to developmental defects in the formation of
primary myofibers at early stages of embryogenesis. These
results demonstrate a heretofore unknown role for the
transcription factor NFAT in skeletal muscle development.
MATERIALS AND METHODS
Animals
Wild-type and NFATC32/2 mice were generated by heterozygous
matings of mice carrying a NFATC3 null mutation (Oukka et al.,
1998). Male mice between 8 and 12 weeks of age were used for
these studies. To obtain staged embryos, breeding pairs were placed
together overnight and examined in the morning for the presence of
a copulation plug. Presence of the copulation plug was designated
as embryonic day 0.5 (E0.5). Individual embryonic and adult mice
were genotyped by PCR analyses of yolk sac or tail DNA, respec-
tively. Primer 59-CCCAAGAAGATCAGAAGACTGTG was used
with primer 59-GCTCTAAAGATGGCTCCGTGCTTAAGG to
amplify a 143-bp fragment from the wild-type allele and with
primer 59-AGCGTTGGCTACCCGTGATATTGCTGAAGA to
amplify a 219-bp fragment from the mutant allele. All animals
were handled in accordance with the institutional guidelines of
Emory University.
Muscle Function Measurements
Maximal isometric tetanic force was measured as described
previously (Warren et al., 1994, 1996). In brief, soleus and EDL
muscles were excised and mounted in a glass chamber maintained
at 25°C. The chamber contained a 95% O2:5% CO2-equilibrated
Krebs–Ringer buffer (pH 7.4) composed of 119 mM NaCl, 5 mM
KCl, 1 mM MgSO4, 1 mM KH2PO4, 25 mM NaHCO3, 1.25 mM
aCl2, 0.17 mM leucine, 0.10 mM isoleucine, 0.20 mM valine, 10
M glucose, 10 mg/ml gentamycin sulfate, and 0.10 U/ml insulin.
The muscle distal tendon was attached via suture to a fixed support
while the proximal tendon was tied to the lever arm of a position-
feedback servomotor (Cambridge Technology Model 300B); muscle
length was adjusted to the length optimal for isometric tetanic
force production. The isometric force–frequency relationship was
then determined using 11 stimulation frequencies, ranging from 5
to 150 Hz for the soleus muscle and from 10 to 200 Hz for the EDL
muscle. The highest force produced during the force–frequency
measurements was taken as the maximal isometric tetanic force.
Relative RT-PCR
RNA was isolated from soleus and EDL muscles of adult
wild-type and NFATC32/2 mice. RT-PCR was performed in dupli-
s of reproduction in any form reserved.
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117Primary Myofiber Defect in NFATC32/2 Micecate for each sample using primers specific for NFATC2 (sense,
59-CCACGAGCTGCCCATGGTGGAGAGACAAGA; antisense,
9-GCAAGCCTCAGTGACAAAGTATCCACTTCA), NFATC1
sense, 59-TCCGGCGCATGCGAGCCGTCATCGACTGTGCT-
GGATCCTGA; antisense, 59-GGACCCGGGTCAATTGGCA-
GAAGGTACGTGAAACG), and NFATC4 (sense, 59-GAG-
AGCCCCTACCGGACTCATC; antisense, 59-AAGGGGCGGG-
AAGGAAGG). All RT was performed using 2.5 mg of total RNA
and all PCR products were amplified in their linear range. To
quantify the amplicons, the PCR reactions were spiked with
a-[32P]dCTP and 18S rRNA was used as an internal control in each
sample using QuantumRNA 18S primers (Ambion, Austin, TX).
The products were resolved using 6% nondenaturing PAGE and
individual band intensities in the dried gel were determined using
a phosphorimager. The density of the amplicons for each NFAT
isoform was normalized to the density of the 18S rRNA amplicon
and expressed as arbitrary units.
Collection of Samples and Morphometric
Measurements
For adult mice, EDL and soleus muscles were collected using
standardized dissection methods, embedded in OCT, and frozen in
isopentane cooled in liquid nitrogen. For E17.5 embryos, the
hindlimbs were removed and similarly frozen. E15 embryos were
collected and fixed in 4% paraformaldehyde for 24 h. Subsequently
they were put through a graded series of 10, 20, and 30% sucrose
solutions, and the hindlimbs were removed and frozen in OCT.
For histological analysis, 14-mm serial sections were collected
along the entire length of the muscles or hindlimbs. At regular
intervals, sections were stained with hematoxylin and eosin and
used for computer-assisted morphometric measurements. The
cross-sectional area of sections throughout the muscle was deter-
mined, and the region spanning the belly of the muscle was
subsequently used for all analyses. Individual fiber areas were
determined by capturing an image in the center of each muscle and
measuring all fibers within this 307,200-mm2 field. All analyses and
photography were performed on an Axioplan microscope equipped
with a video camera and Scion Image and Adobe Photoshop
software.
Immunohistochemistry
Antibodies. The antibodies used in this study and their speci-
ficities are given in Table 1. Fibers expressing only Type IIx myosin
heavy chain (MyHC) were identified by the lack of staining with a
mixture of BF-F3 and N2.261. MyHC antibodies were obtained
either from the American Type Tissue Collection (Rockville, MD)
or from the Developmental Studies Hybridoma Bank (Iowa City,
IA). Secondary antibodies were obtained from Jackson Immuno-
chemicals (West Grove, PA) and Cappel/Organon Teknika
(Durham, NC). In some experiments, a TSA green direct kit (NEN
Life Sciences, Boston, MA) was used to detect binding of the
primary antibodies.
Adult. Quadruplicate sections for each antibody were blocked
with 5% horse serum in PBS and incubated in each primary
antibody (BAD5, 1:30; My32, 1:1000; SC71, 1:5; BFF3, 1:5; BFF3 1
N2.261, 1:5) at room temperature for 1 h. After washing in PBS 1
0.05% Tween 20 (PBST), the sections were incubated in biotinyl-
ated goat anti-mouse (1:250). Following further washes in PBST,
the slides were incubated in Vectastain Elite ABC reagent (Vector
Copyright © 2001 by Academic Press. All rightLabs, Burlingame, CA), and antibody binding was detected with
diaminobenzidine. No staining was observed in control sections
incubated with the secondary antibody alone. Analyses were per-
formed by counting the number of fibers expressing a particular
MyHC in each section two separate times, tagging the fibers to
avoid double counting. The average number per section was
subsequently determined and used to calculate the mean number
of fibers expressing each MyHC type in the quadruplicate sections.
E15. Sections spanning the entire length of the EDL were
treated with 0.3% H2O2 in methanol, washed in PBS, blocked with
NB (NEN Life Sciences), and incubated with 4A.1025 (neat) at
°C overnight. After washing in TNT (0.1 M Tris–HCl, pH 7.5, 0.15
NaCl, 0.05% Tween 20), the sections were incubated in Texas
ed goat anti-mouse (1:50). After further washing in TNT, the slides
ere mounted in Vectashield mounting media (Vector Labs). The
otal number of primary myofibers was counted for each of 10–12
ections throughout the EDL, and the mean number of myofibers
er EDL was calculated.
E17.5. Sections spanning the belly of the EDL were treated
ith 0.3% H2O2 in methanol, washed in PBS, blocked with TNB,
and incubated with the primary antibodies (A4.840, neat, and
laminin, 1:1500) at 4°C overnight. After washing in TNT, the
sections were incubated in HRP donkey anti-rabbit (1:250) and
Texas red goat anti-mouse (1:50). After further washes in TNT, the
sections were incubated in the TSA green reagent (NEN Life
Sciences) diluted 1:50 in amplification buffer. The slides were
washed and mounted as for E15. No staining was observed in
control sections incubated with secondary antibodies alone.
Primary and secondary myofibers were classified based on Type
I MyHC expression, as well as size and location criteria (Condon et
al., 1990; Harris et al., 1989b; Narusawa et al., 1987; Rubinstein
nd Kelly, 1981). Primary myofibers were large and expressed Type
MyHC, whereas secondary myofibers were smaller, did not
xpress Type I MyHC, and were located underneath the basal
amina of a primary myofiber. The density of primary and second-
ry myofibers was determined by counting the number of myofi-
ers per 49,150-mm2 field for each EDL. The total number of
primary myofibers in each EDL was counted for each of eight serial
sections, and the mean number of myofibers per EDL was calcu-
TABLE 1
Specificity of the Antibodies
Antibody
name Antigen recognized Source
BA-D5 Type I MyHC (Schiaffino et al., 1989)
My32 All Type II MyHC Sigma
SC-71 Type IIa MyHC (Bottinelli et al., 1991)
BF-F3 Type IIb MyHC (Schiaffino et al., 1989)
A4.480 Embryonic slow MyHC (Webster et al., 1988)
(Hughes et al., 1993)
N2.261 Type I and IIa MyHC (Webster et al., 1988)
(Hughes et al., 1993)
4A.1025 All MyHC (Webster et al., 1988)
(Hughes et al., 1993)
— Laminin R & D Systemslated.
s of reproduction in any form reserved.
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118 Kegley et al.RESULTS
Fast and Slow Muscles of NFATC32/2 Mice Are
Decreased in Size
To screen for phenotypic changes arising from the lack of
NFATC3 in skeletal muscle, isolated soleus and EDL
muscles of adult wild-type and NFATC32/2 mice were
compared on size-dependent and -independent measures of
functional capacity (e.g., maximal isometric tetanic force,
maximal shortening velocity). The isometric strength of
soleus and EDL muscles in NFATC32/2 mice is signifi-
cantly decreased, with EDL muscles being more severely
affected (Figs. 1A and 1B). The decrease in isometric
strength in NFATC32/2 muscles is fully accountable for by
the decrease in muscle weights shown in Figs. 1C and 1D.
The weights of the soleus and EDL in NFATC32/2 mice are
ignificantly decreased as compared to wild type, with EDL
uscles being more severely affected (Figs. 1C and 1D).
DL muscles exhibit a decrease of 25% as compared to a
ecrease in the soleus of 13%. In contrast, body weight did
FIG. 1. NFATC32/2 mice display reduced isometric strength and
oth the soleus and the EDL muscles from NFATC32/2 mice com
muscles from NFATC32/2 mice is also significantly decreased comot differ between wild-type and NFATC32/2 mice (Table
Copyright © 2001 by Academic Press. All right2). Therefore, no intrinsic differences exist in the contrac-
tile isometric force-producing properties of soleus and EDL
muscles in NFATC32/2 mice. However, the mutant
uscles are smaller, suggesting that NFATC3 plays a role
n regulating muscle mass.
To study whether compensatory changes in other NFAT
soforms occur in the absence of NFATC3 and could con-
ribute to the observed phenotype, we analyzed the expres-
ion of the other three known calcium-responsive NFAT
cle weight. (A, B) Maximal isometric tetanic force is decreased in
d to NFATC31/1 mice. (C, D) The weight of the soleus and EDL
to NFATC31/1 mice. Data are means 6 SE; n 5 3–5; * P , 0.05.
TABLE 2
Body Weight Is Unaffected by the Absence of NFATC3
Genotype
Body weight (g)
Male (n) Female (n)
1/1 24.7 6 0.72 (5) 19.0 6 0.22 (5)
2/2 23.8 6 0.80 (5) 18.5 6 0.95 (4)mus
pareData are means 6 SE.
s of reproduction in any form reserved.
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119Primary Myofiber Defect in NFATC32/2 Miceisoforms in the soleus and EDL muscles. RT-PCR was
performed on RNA isolated from wild-type and NFATC32/2
muscles using gene-specific primers and normalized to the
expression of 18S ribosomal RNA. NFATC4 expression is
not detected in muscles from either genotype (data not
shown). The expression of NFATC2 and NFATC1 does not
significantly differ between wild-type and mutant muscles
(Fig. 2). It should be noted that this assay does not allow
comparisons of the relative amounts of the two different
NFAT isoforms, but rather gives comparisons of a single
NFAT isoform between wild type and mutant. Thus, the
absence of NFATC3 does not alter the expression of other
NFAT isoforms in these skeletal muscles.
The Decrease in Muscle Mass Is Accounted for by
Fewer Myofibers in NFATC32/2 Mice
Several possibilities exist to account for the loss of
muscle mass in NFATC32/2 muscles. Either the number of
yofibers is the same in both types of mice, but myofibers
re atrophied or blunted in growth in the NFATC3 mutant,
r the size of the myofibers is the same, but the number of
yofibers is decreased in the mutant. A combination of
hese scenarios is also possible. In order to distinguish
mong these possibilities, soleus and EDL muscles were
nalyzed for myofiber area and number. No difference
xists in the areas of either Type I or Type II myofibers in
he soleus or EDL muscles of wild-type and mutant mice
Fig. 3, top). However, the total number of myofibers is
ignificantly decreased by 20% in both the mutant soleus
nd the EDL muscles (Fig. 3, bottom). Thus, the smaller
uscle mass exhibited in both muscles of the mutants is
ue to a difference in the number of myofibers, suggesting a
ole for NFATC3 in regulating myofiber number rather
FIG. 2. Absence of NFATC3 does not alter the expression of other
FAT isoforms in skeletal muscle. RT-PCR of RNA prepared from
ild-type and NFATC32/2 soleus and EDL muscles was performed
or various NFAT isoforms and normalized to the expression of 18S
ibosomal RNA. The expression of NFATC2 and NFATC1 is not
ltered significantly in NFATC32/2 muscles as compared to wild
type. NFATC4 is not expressed in either wild-type or NFATC32/2
muscles (data not shown). Data are means 6 SE; n 5 5 for each
genotype.han size. f
Copyright © 2001 by Academic Press. All rightReduced Myofiber Number in NFATC32/2 Mice Is
not Limited to a Specific Fiber Type
To determine if the decreased number of myofibers in
NFATC32/2 muscles is selective for a specific myofiber
type, serial sections were stained with antibodies recogniz-
ing specific MyHC types: Type I, IIa, and IIb. All fiber types,
except those fibers expressing solely Type IIx MyHC, are
significantly decreased in number in both soleus (Fig. 4, top)
and EDL (Fig. 4, bottom) muscles of NFATC32/2 mice.
owever, no change in fiber-type proportions was present
data not shown). As no specific Type IIX antibody is
vailable, we relied on costaining sections with antibodies
hat recognize Types I, IIa, and IIb MyHC and counting the
nstained myofibers as Type IIx. It is possible that Type IIx
s coexpressed in other fibers but our antibody staining
ethod cannot detect its expression in these fibers. Thus,
he reduced fiber number in NFATC32/2 mice is not limited
to a specific MyHC type, but affects a number of fiber types.
FIG. 3. Decreased muscle weight is due to a reduction in total
myofiber number. Serial sections of NFATC31/1 (open bars) and
NFATC32/2 (filled bars) soleus and EDL muscles were stained with
ntibodies against Type I or Type II MyHC. Myofiber area (top) and
umber (bottom) were determined. No significant differences exist
n the areas of either Type I or Type II MyHC expressing myofibers
etween NFATC31/1 and NFATC32/2 muscles. The total number
of myofibers is significantly decreased in NFATC32/2 soleus and
EDL muscles (* P , 0.05). Data are means 6 SE; for myofiber area,
5 3. For myofiber number, n 5 3 for NFATC31/1 and n 5 6–8
or NFATC32/2.
s of reproduction in any form reserved.
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120 Kegley et al.Developmental Defect in Myogenesis Occurs in
NFATC32/2 Mice
The reduced number of myofibers present in adult
NFATC32/2 animals could be due either to a developmental
problem during embryogenesis or to postnatal death of
myofibers. To distinguish between these two possibilities,
we analyzed muscles of embryonic mice. Since the mass of
the EDL muscle is more severely affected by the lack of
NFATC3, the analysis was restricted to this muscle. Em-
bryos were analyzed at E17.5 since the EDL muscle has
attained the adult number of myofibers by this stage in
mouse embryogenesis (Ontell and Kozeka, 1984) and evi-
dence of a developmental defect would be apparent at this
stage. Hindlimbs from wild-type and NFATC32/2 embryos
ere immunostained with antibodies against laminin in
rder to delineate individual muscles clearly. As seen in Fig.
, EDL muscles of NFATC32/2 embryos at this time point
FIG. 4. The decrease in the number of myofibers is not limited to
a specific type. Serial sections of soleus (top) and EDL (bottom)
muscles of NFATC31/1 (open bars) and NFATC32/2 (filled bars)
mice were stained with antibodies against specific MyHC types.
The number of myofibers expressing Type I, IIa, and IIb MyHC was
determined. The number of fibers expressing only Type IIx MyHC
was determined by counting fibers left unstained after incubation
with a mixture of antibodies against the other three MyHC types.
In both the soleus and the EDL muscles, NFATC32/2 mice display
a significant decrease in the number of Type I, IIa, and IIb myofibers
(* P , 0.05). No difference is noted in the number of fibers that
xpress only Type IIx MyHC. Data are means 6 SE; n 5 3 for
FATC31/1 and n 5 6–8 for NFATC32/2.n development are decreased in cross-sectional area as N
Copyright © 2001 by Academic Press. All rightompared to wild-type embryos. These results indicate a
eleterious effect of the lack of NFATC3 on embryonic
uscle development rather than causing postnatal fiber
eath.
Impairment of Primary Myogenesis in NFATC32/2
Embryos
The process of myofiber formation during embryogenesis
is discontinuous and occurs as two sequential waves. Pri-
mary myofibers form first, and after a delay are followed by
secondary myofibers (Harris et al., 1989a; Kelly and Zacks,
1969; Ontell and Kozeka, 1984; Ross et al., 1987a). The
ecrease in the size of EDL muscles in NFATC32/2 embryos
ould be due either to impairment in primary or secondary
yogenesis or to a combination of the two. Primary myo-
ber formation begins at approximately E12 in the mouse
DL (Ontell and Kozeka, 1984) due to the fusion of embry-
nic myoblasts and is complete by E15. At approximately
15.5, a second population of myoblasts, termed fetal
yoblasts, begin to fuse with one another to form second-
ry myofibers, using the primary myofibers as a scaffold.
econdary myofibers form beneath the basal lamina of
rimary myofibers, and as the secondary myofibers increase
n size, they bud off from the myofibers and are surrounded
ntirely by their own basal lamina.
To determine if primary myogenesis is aberrant in the
bsence of NFATC3, the hindlimbs of wild-type and
FATC32/2 embryos were collected at E15. This timepoint
was chosen for analysis because primary myogenesis is
complete in the EDL of wild-type embryos, and secondary
myogenesis is just beginning, with only a few very small
secondary myofibers present. The total number of primary
myofibers was determined for each of 10–12 sections
throughout the EDL muscles of wild-type and NFATC32/2
embryos and averaged. The number of primary myofibers is
significantly reduced by 18% in the mutant EDL muscles as
FIG. 5. The decrease in NFATC32/2 muscle size is due to a
developmental defect during embryogenesis. Hindlimbs were col-
lected from E17.5 NFATC31/1 and NFATC32/2 embryos and serial
ections in the belly of the EDL muscle were stained with an
ntibody against laminin. The cross-sectional area of EDL muscles
rom NFATC31/1 embryos is larger than that of NFATC32/2
embryos. Bar 5 100 mm. Data are means 6 SE; n 5 3 for
FATC31/1 and n 5 4 for NFATC32/2.
s of reproduction in any form reserved.
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121Primary Myofiber Defect in NFATC32/2 Micecompared to controls (Fig. 6), indicating that primary myo-
genesis is altered in the absence of NFATC3.
The total number of primary fibers was also assessed at
E17.5 in order to address two additional questions. First, is
primary myofiber formation simply delayed in the absence
of NFATC3? If the rate of primary myofiber formation were
slowed in the mutant, we would expect that the number of
primary myofibers would increase at the later time point.
Second, are primary myofibers degenerating in the absence
of NFATC3? If primary myofibers in the mutant were
formed initially, but were then dying at an increased rate,
we would expect that the difference in the total number of
primary myofibers between wild-type and mutant muscles
would increase at the later time point. At E17.5, primary
and secondary myofibers are clearly discernable due to
myofiber size and differential expression of slow MyHC.
Hindlimbs were immunostained with antibodies against
both slow MyHC and laminin. Slow MyHC was used to
distinguish primary fibers (Fig. 7 inset, left), and laminin
was used to aid in the identification of secondary fibers by
verifying if a myofiber lies under the basal lamina of the
slow MyHC expressing primary myofiber (Fig. 7 inset,
right). In addition, since a small percentage of the primary
fibers do not express slow MyHC at this stage, size and
location criteria were also used in classifying the fibers. The
total number of primary myofibers in the EDL muscles of
NFATC32/2 embryos is significantly decreased by 18%
compared to wild type (Fig. 7, left), which is equivalent to
the decrease observed at E15 indicating that primary myo-
fiber formation is not simply slowed in the absence of
NFATC3. Furthermore, these results indicate that in-
creased primary myofiber death does not occur in the
mutant between E15 and E17.5. In addition, the cross-
sectional area of individual primary myofibers was deter-
FIG. 6. Primary myogenesis is impaired in NFATC32/2 embry-
onic muscle. Hindlimbs were collected from E15 NFATC31/1 and
FATC32/2 embryos, and serial sections along the entire length of
the EDL muscle were stained with an antibody that recognizes all
MyHC isoforms. The number of primary myofibers was deter-
mined as described under Materials and Methods. The total num-
ber of primary myofibers in the EDL is significantly decreased 18%
in NFATC32/2 mice (* P , 0.05). Data are means 6 SE; n 5 6 for
NFATC31/1 and n 5 5 for NFATC32/2.mined in the EDL and does not differ between wild-type and
Copyright © 2001 by Academic Press. All rightFATC32/2 embryos (Fig. 7, right), indicating that once the
primary myofibers form, normal maintenance and growth
occurs. Taken together, these results suggest that NFATC3
plays a role in regulating events that control the normal
balance among proliferation, terminal differentiation, and
survival of embryonic myoblasts during the onset of pri-
mary myogenesis.
Existing Primary Myofibers in the Mutant Support
Normal Secondary Myogenesis
To determine whether impaired primary myogenesis is
solely responsible for the reduced fiber number seen in the
adult, further analyses were performed to determine if the
process of secondary myogenesis is also aberrant in the
absence of NFATC3. The number of primary myofibers
indirectly influences the number of secondary myofibers
since primary myofibers serve as a scaffold for the forma-
tion of secondary myofibers. Since the number of primary
myofibers is decreased in the mutant embryos, we could
FIG. 7. Primary myofiber number in the mutant does not undergo
further changes relative to wild type at a later time in development.
Hindlimbs were collected from E17.5 NFATC31/1 and NFATC32/2
embryos, and serial sections in the belly of the EDL were costained
with antibodies against laminin (green) or Type I MyHC (red).
(Inset) Fibers were classified as primary (arrows) or secondary
(asterisks) based on the criteria of fiber size, location, and the
presence or absence of Type I MyHC expression. Left, bar 5 50 mm.
ight, bar 5 10 mm. The total number (left) and cross-sectional area
right) of primary myofibers in the belly of the EDL was determined
or NFATC31/1 and NFATC32/2 embryos. The total number of
rimary myofibers in the EDL is significantly decreased by 18% in
FATC32/2 mice (* P , 0.05). No significant difference exists in
the cross-sectional area of primary myofibers. Data are means 6 SE;
n 5 3 for NFATC31/1 and n 5 4 for NFATC32/2.
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122 Kegley et al.not simply count the total number of secondary myofibers
in the EDL to examine the intrinsic process of secondary
myogenesis in NFATC32/2 embryonic muscle. Thus, we
sed the density of primary and secondary myofibers per
nit field as a means of assessing whether each primary
yofiber in the mutant is able to support the development
f an equal number of secondary myofibers as in the wild
ype. First, we verified that the density of primary myofi-
ers per field is equivalent in embryonic wild-type and
FATC32/2 EDL muscles. No significant difference is ob-
served in the density of primary myofibers in wild-type and
NFATC32/2 EDL muscles (Fig. 8, left). These results indi-
cate that in the absence of NFATC3, normal myofiber
patterning occurs despite the decreased total myofiber
number. Next, the number of secondary myofibers per field
was assessed and does not differ significantly between wild
type and NFATC32/2 (Fig. 8, right), suggesting that an
individual primary myofiber in the mutant can support the
development of an equivalent number of secondary myofi-
bers as in the wild type. Therefore, secondary myogenesis
does not appear to be intrinsically altered in the absence of
NFATC3. Taken together, these results suggest that once
primary myofibers form in the mutant, a normal course of
development is followed. A requirement for NFATC3 exists
during an early event in embryogenesis, which ultimately
controls the formation of the correct number of primary
muscle fibers.
DISCUSSION
Myofiber formation during mammalian embryogenesis
occurs in two sequential waves. Primary myofibers form
first and are followed after a delay by secondary myofibers
(Harris et al., 1989a; Kelly and Zacks, 1969; Ontell and
ozeka, 1984; Ross et al., 1987a). The reduced mass and
yofiber number observed in muscles of adult NFATC32/2
mice is due to a developmental defect occurring at the early
FIG. 8. Secondary myogenesis is not altered in NFATC32/2
muscle. Hindlimbs of E17.5 embryos were collected and stained as
in Fig. 7. The number of primary and secondary fibers was deter-
mined per 49, 150-mm2 field. The density of primary and secondary
yofibers is not altered in NFATC32/2 embryos as compared to
NFATC31/1 embryos. Data are means 6 SE; n 5 3 for NFATC31/1
and NFATC32/2.periods of muscle formation. The number of primary myo-
Copyright © 2001 by Academic Press. All rightbers is decreased significantly in NFATC32/2 embryos by
he end of the primary myogenesis period (E15). At E17.5,
quivalent decreases in the number of primary myofibers
re still observed in the mutant relative to wild type. Thus,
rimary myofiber formation is not simply delayed nor are
he myofibers undergoing abnormal degeneration during
his period in the absence of NFATC3. Once primary
yogenesis is complete in NFATC32/2 embryos, the exist-
ng primary myofibers, albeit fewer, undergo normal growth
nd patterning within the tissue and support the process of
econdary myogenesis normally.
Defects in embryonic muscle development also occur in
ice lacking other transcription factors such as myogenic
egulatory factors, proto-oncogenes, and homeobox genes.
efects in tyrosine kinase intracellular signaling pathways,
uch the hepatocyte growth factor (HGF)/c-met ligand/
eceptor pair also lead to prominent defects in myogenesis.
hese phenotypes include the following:
(1) A total lack of muscle fibers is observed in mice
acking both myoD and myf5 (Rudnicki et al., 1993).
mbryos deficient in c-met, the receptor for HGF, lack
uscles (Bladt et al., 1995) deriving from migratory precur-
sors such as limb muscles. Similarly, mice deficient in
homeobox genes expressed in migrating limb precursor
cells such as Lbxh1 (Gross et al., 2000; Schafer and Braun,
1999) or Pax3 (Daston et al., 1996) exhibit extensive loss of
limb muscle.
(2) Primary myogenesis is delayed by approximately 2.5
days in myoD- or myf5-deficient embryos but eventually
the musculature develops normally (Kablar et al., 1997).
(3) Secondary myofiber formation is effected in a larger
number of mouse mutants. Elimination of myogenin
(Venuti et al., 1995) profoundly alters secondary myogen-
esis. Interfering with signal transduction through the HGF-
met pathway by inhibiting the ability of c-met to bind Grb2
(Maina et al., 1996) also leads to a generalized deficit in
secondary fibers. Mice deficient in the proto-oncogene ski
exhibit decreases in muscle mass resulting from a decrease
in fiber size and density (Berk et al., 1997). These authors
suggest that the phenotype is most consistent with a defect
in secondary myogenesis due to problems in the expansion
or survival of fetal myoblasts. The defect caused in skeletal
muscle by the absence of NFATC3 does not mimic any of
these previously observed phenotypes observed in knock-
out mice.
In what cell type is the expression of NFATC3 required
during development in order for primary myogenesis to
occur normally? Unfortunately we were not able to use
currently existing antibodies against NFATC3 to character-
ize the cellular localization of activated NFATC3 during
development due to cross-reacting epitopes expressed in
skeletal muscle tissue during development. Characteriza-
tion of RNA expression is not sufficient because nuclearly
localized NFAT proteins are the active transcription fac-
tors. However, one required site of action for NFATC3
could be skeletal muscle cells themselves. That primary
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123Primary Myofiber Defect in NFATC32/2 Micemyogenesis is altered and not secondary myogenesis may
be due to the fact that distinct types of myoblasts are found
at the embryonic, fetal, and neonate/adult stages of devel-
opment (Miller et al., 1993; Stockdale, 1992) that are known
o differ in their biochemical properties. NFATC3 may be
equired for the function of embryonic myoblasts, which
re responsible for primary myofiber formation, but not for
etal myoblasts, which are responsible for secondary myo-
enesis. Embryonic and fetal myoblasts are known to differ
n other intracellular signaling pathways (Cossu et al.,
988; Cusella-De Angelis et al., 1994; Zappelli et al., 1996).
Further support for the idea that NFATC3 is required in
some types of myoblasts and not others are studies showing
that muscle regeneration is not altered in adult NFATC32/2
mice (Horsley and Pavlath, unpublished data), a process
dependent on adult satellite myoblasts.
Requirements for NFATC3 in nonmuscle cells may also
contribute to the impairment of primary myogenesis that
occurs in the absence of NFATC3. These include the
following:
(1) Cells in the immature somite are multipotent and are
dependent on the surrounding tissues for specification.
Several signaling molecules produced by the surrounding
tissues have been proposed as positive effectors of myogen-
esis (for review, see Tajbakhsh and Buckingham, 2000).
These include Wnts present in the neural tube and in the
surface ectoderm and Sonic hedgehog produced by the
notochord and the neural tube. In the absence of NFATC3
such signals may not occur in an optimal manner.
(2) Maternal malnutrition has been shown to decrease
the number of muscle fibers that form during development
(Aberle, 1984; Dwyer et al., 1994; Wilson et al., 1988).
However malnutrition affects secondary myofiber forma-
tion (Aberle, 1984; Wilson et al., 1988) not primary myofi-
bers. Furthermore, the differences in primary myofiber
number were observed between wild-type and NFATC32/2
littermates.
(3) Defects in nerve are also unlikely to be the cause of
the observed phenotype in the mutant as primary myofibers
develop autonomously of innervation (Crow and Stockdale,
1986; McLennan, 1983). Furthermore, no changes in MyHC
proportions are present in adult mice. The pattern of MyHC
expression is known to be exquisitely sensitive to innerva-
tion in the adult. Furthermore, the defect we observe in
NFATC32/2 embryos is not phenocopied by either genetic
(Ashby et al., 1993a,b) or experimental (Ross et al., 1987b;
Houenou et al., 1990; McLennan, 1983) alterations in
innervation during development. Development of the ante-
rior muscles of the hindlimb in the mouse mutant peroneal
muscular atrophy occurs in the absence of innervation.
Ashby et al. (Ashby et al., 1993a,b) observed degeneration of
primary myofibers in peroneal muscular atrophy mice be-
tween E12 and E15 with a concomitant increase in the
density of secondary fibers at later stages. These mice
exhibit severe defects in muscle postnatally and die within
several weeks after birth (Blondet et al., 1989). m
Copyright © 2001 by Academic Press. All rightRegardless of whether the critical requirement for
FATC3 is in muscle or nonmuscle cells, several early
teps in embryonic muscle development could be altered by
he absence of NFATC3. These include the following:
(1) Decreases in the number of embryonic myoblasts
resent within the limb buds themselves. A reduction in
he number of myoblasts could occur for several reasons. A
ormal number of myogenic progenitor cells may form and
roliferate in the dermomyotome but the cells may have
ecreased ability to migrate to the limb buds. Alternatively,
he migration process may be normal but fewer myogenic
rogenitor cells are generated in the dermomyotome ini-
ially. Furthermore, myogenic progenitor cells deficient in
FATC3 may exhibit decreased survival at any stage from
heir formation in the dermomyotome through migration
nto and finally arrival in the limb bud. Defects in apoptosis
ave been suggested to occur in activated T cells in adult
FATC32/2 animals (Oukka et al., 1998).
(2) Mutant myoblasts may have decreased ability to
roliferate and/or differentiate upon their arrival in the
imb bud. Defects in differentiation are unlikely to contrib-
te to the observed phenotype for several reasons. The
rimary myofibers that are present during development are
f normal size. In addition, a calcineurin-dependent path-
ay has been shown to be required for muscle differentia-
ion, but the downstream effector is not NFAT (Friday et
l., 2000). Furthermore, the differentiation and fusion of
FATC32/2 myoblasts derived from adult mice appears
normal in vitro (G. K. Pavlath, unpublished observations).
(3) Primary myofibers may form normally but increased
numbers may die by E15, the time of our first analyses.
Such myofiber degeneration has been shown to occur in the
peroneal muscular atrophy mutant but further defects in
secondary myofibers were subsequently noted (Ashby et al.,
1993a,b). Clearly future studies are required and should be
directed toward delineating which of these early steps
necessary for primary myogenesis are altered by the absence
of NFATC3.
In summary, we demonstrate that the calcium- and
calcineurin-regulated transcription factor NFATC3 contrib-
utes to primary myogenesis. Although a number of proteins
are known to regulate events required for myogenesis in the
early embryo, far less is known of the intracellular signaling
pathways utilized during muscle development. Our results
suggest that NFATC3 plays a role in regulating events that
control the normal balance among proliferation, terminal
differentiation, and survival of embryonic myoblasts during
the onset of primary myogenesis. Calcium signaling path-
ways have been proposed previously to play a role in somite
maturation and myocyte differentiation in Xenopus (Ferrari
and Spitzer, 1999). Furthermore, inhibition of calcineurin
using the inhibitor cyclosporine A leads to fetal malforma-
tions (Pickrell et al., 1988; Uhing et al., 1993).
Our results demonstrate a heretofore unknown role for
he transcription factor NFAT in skeletal muscle develop-
ent. The NFAT family of proteins appear to regulate a
s of reproduction in any form reserved.
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124 Kegley et al.number of developmental decisions in diverse cell types
such as adipocytes (Ho et al., 1998), chondrocytes (Ranger et
l., 2000), T cells (Rao, 1994), and cardiac tissue (Ranger et
l., 1998; Molkentin et al., 1998). A future challenge will be
to elucidate the genes that are regulated by NFAT and act to
control and modulate development and differentiation of
specialized cell types.
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